Methcure 0.2mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Methylergometrine (0.2mg)
Overview Methcure 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy may be managed with a 0.2mg injection of Methcure. This medication acts on uterine smooth muscle, enhancing its contractility (tone, rate, and amplitude of contractions), thereby minimizing postpartum hemorrhage. Administration is strictly by a physician intravenously or intramuscularly in a hospital setting; self-medication is prohibited. Dosage and frequency are determined by the treating physician based on individual needs and condition. Treatment aims to alleviate symptoms, with dosage adjustments as needed. Common adverse effects include headache, elevated blood pressure, and seizures. Report any concerning side effects promptly to your doctor; management strategies may be available. Alcohol consumption should be avoided during treatment. Prior to commencing therapy, inform your doctor of any pre-existing heart conditions or hypertension, and provide a complete list of all current medications, as interactions may affect Methcure's efficacy or mechanism of action.
Primary Ingredients of Methcure 0.2mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Methcure 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Methcure 0.2mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
Common Side effects of Methcure 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Methcure 0.2mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Methcure 0.2mg Injection works:
Ergotamine-based Methcure 0.2mg Injection induces prolonged uterine smooth muscle contractions. This vascular compression effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Methcure 0.2mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyUNSAFE
Administering Methcure 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use, given that research in both animal and human subjects has revealed considerable adverse effects on fetal development.
Breast feedingCAUTION
Administering Methcure 0.2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Methcure 0.2mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Methcure 0.2mg Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Methcure 0.2mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Methcure 0.2mg Injection :
NA
Facts to Know About Methcure 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Actions | Drugs inducing uterine contraction and abortion |
3,018 People bought this recently